Pay in 4 interest-free payments of $6.29 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
Ozempic (semaglutide) is a prescription drug in a class of medications called GLP-1 agonists (a/k/a glucagon-like peptide-1 receptor agonists, GLP-1 receptor agonists GLP-1-RA, incretin mimetics, or GLP-1 analogs) that have been used to treat type 2 diabetes and obesity by lowering blood sugar, helping the pancreas produce more insulin, and slowing the rate that food passes through the body
Pathological staging was performed in accordance with the Scheuer and Nakanuma classifications (SC and NC)
GLP-1 medications suppress appetite artificially
The case studys pharmacological intervention was the administration of semaglutide following the standard titration protocol: the patient was first prescribed 0.25 mg subcutaneously once weekly in August 2024
In addition, GLP-1 therapies appear to promote natriuresis, or increased sodium excretion, through effects on the kidneys
.jpg)
Michael is committed to providing culturally responsive care and supports individuals of all backgrounds with respect to sex, race, religion, and sexual orientation
